Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Herpes simplex vaccine comprising HSV glycoprotein GD and 3 deacylated monophosphoryl lipid A

Herpes simplex vaccine comprising HSV glycoprotein GD and 3 deacylated monophosphoryl lipid A

US Patent 6027730 · Granted Feb 22, 2000

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inactivated dengue virus vaccine with aluminium-free adjuvant2016
Vaccine2015
Methods for one-dose intradermal delivery for non-live trivalent influenza vacci2015
Vaccine2015
Process for the production of immunogenic compositions2013
Non-live trivalent influenza vaccine for one-dose intradermal delivery2013
MAGE3 polypeptides2012
Process for the production of immunogenic compositions2011
Composition2007
Vaccine composition containing adjuvants2006
Vaccine composition containing adjuvants2006
Vaccine composition containing adjuvants2006